Is It Time to Buy These 4 Dialysis Stocks?
Should you consider buying these four dialysis stocks -- DaVita, Fresenius, NxStage, and Rockwell -- since the Centers for Medicare and Medicaid Services changed its tune on reducing payments to kidney dialysis providers?
3 Horrendous Health-Care Stocks This Week
NxStage Medical, Immunogen, and Repros Therapeutics make this week's most horrendous health-care performers.
Why NxStage Medical Inc. Shares Slumped
NxStage delivers strong third-quarter revenue growth but leaves shareholders hanging when dishing out its fourth-quarter guidance.